Antibody Analytics
Antibody Analytics is a leading provider of testing services to support the discovery and characterisation of therapeutics in the oncology space. Built to empower drug developers from initial discovery throughout drug development to make better, more informed analytical decisions, Antibody Analytics pride themselves on taking their ‘late stage’ experience and applying it early to their customer’s discovery and preclinical pipelines.
Scientists turn to Antibody Analytics when they are looking to characterize their molecules in in vitro systems that model in vivo interactions. As the name suggests, the team have a lot of experience working with antibody-based therapies, however with their primary immune cell and binding capabilities, Antibody Analytics also support investigation and in vitro characterisation of small molecules, cell therapies and other biologic entities.
Antibody Analytics is a leading provider of testing services to support the discovery and characterisation of therapeutics in the oncology space. Built to empower drug developers from initial discovery throughout drug development to make better, more informed analytical decisions, Antibody Analytics pride themselves on taking their ‘late stage’ experience and applying it early to their customer’s discovery and preclinical pipelines.
Scientists turn to Antibody Analytics when they are looking to characterize their molecules in in vitro systems that model in vivo interactions. As the name suggests, the team have a lot of experience working with antibody-based therapies, however with their primary immune cell and binding capabilities, Antibody Analytics also support investigation and in vitro characterisation of small molecules, cell therapies and other biologic entities.
Chime Biologics
Chime Biologics was established in 2013 as the world's first modular biopharmaceutical manufacturing facility (GE KuBio). The facility is equipped with multiple 2,000 L, 500 L and 200 L single-use bioreactors for clinical and commercial GMP manufacturing and operated in compliance with US FDA, EMA, NMPA GMP standards.
We offer fully integrated CDMO services that enables robust, cost-effective and timely production of unrivalled quality therapeutics including monoclonal antibodies, bispecific antibodies, fusion proteins and enzymes from early-stage development through late-stage clinical and commercial manufacturing.
Chime Biologics was established in 2013 as the world's first modular biopharmaceutical manufacturing facility (GE KuBio). The facility is equipped with multiple 2,000 L, 500 L and 200 L single-use bioreactors for clinical and commercial GMP manufacturing and operated in compliance with US FDA, EMA, NMPA GMP standards.
We offer fully integrated CDMO services that enables robust, cost-effective and timely production of unrivalled quality therapeutics including monoclonal antibodies, bispecific antibodies, fusion proteins and enzymes from early-stage development through late-stage clinical and commercial manufacturing.
VIVEbiotech
VIVEbiotech is a GMP CDMO fully focused on the development and GMP manufacture of lentiviral vectors from very early stages to GMP. Being fully focused on customers´projects, VIVEbiotech adapts to their requirements being highly flexible in terms of technical adaptation and slots availability.
VIVEbiotech is currently working for clients based in Europe, USA and Asia, manufacturing lentiviral vectors for different applications such as rare diseases as well as immune-oncology (CAR-Ts, TCRs, CAR-NKs, TILs), among others.
One of VIVEbiotech´s main features is its specialization in virology. Based on it, the R&D department is focusing its efforts on the development of more cost-effective processes and safer lentiviral vectors (worldwide patented technology called Lentisoma).
VIVEbiotech is a GMP CDMO fully focused on the development and GMP manufacture of lentiviral vectors from very early stages to GMP. Being fully focused on customers´projects, VIVEbiotech adapts to their requirements being highly flexible in terms of technical adaptation and slots availability.
VIVEbiotech is currently working for clients based in Europe, USA and Asia, manufacturing lentiviral vectors for different applications such as rare diseases as well as immune-oncology (CAR-Ts, TCRs, CAR-NKs, TILs), among others.
One of VIVEbiotech´s main features is its specialization in virology. Based on it, the R&D department is focusing its efforts on the development of more cost-effective processes and safer lentiviral vectors (worldwide patented technology called Lentisoma).
IMed Consultancy
IMed Consultancy are a specialist medical device quality and regulatory consultancy based in Bloxham, UK. Operating with clients in the UK, Europe and Global markets, IMed’s specialist team have a breadth of experience in the regulatory and quality fields and all have a background in the Medical Device manufacturing industry. IMed act as a registered UK Responsible Person for overseas manufacturers selling devices in the UK.
IMed have assisted many companies taking a variety of devices to market; from swabs, test-tubes and face coverings, to scanners, software and pacemakers. Specialising not only in medical devices but also In Vitro Diagnostics, IMed have expertise in all major medical regulatory standards such as Global Registrations, Regulatory transitions, gap analysis, internal auditing and management review. IMed have in-house quality systems specialists and a strong medical writing team, creating clinical evaluation reports and other scientific documentation.
IMed Consultancy are a specialist medical device quality and regulatory consultancy based in Bloxham, UK. Operating with clients in the UK, Europe and Global markets, IMed’s specialist team have a breadth of experience in the regulatory and quality fields and all have a background in the Medical Device manufacturing industry. IMed act as a registered UK Responsible Person for overseas manufacturers selling devices in the UK.
IMed have assisted many companies taking a variety of devices to market; from swabs, test-tubes and face coverings, to scanners, software and pacemakers. Specialising not only in medical devices but also In Vitro Diagnostics, IMed have expertise in all major medical regulatory standards such as Global Registrations, Regulatory transitions, gap analysis, internal auditing and management review. IMed have in-house quality systems specialists and a strong medical writing team, creating clinical evaluation reports and other scientific documentation.